Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic

被引:271
作者
StetlerStevenson, WG
Hewitt, R
Corcoran, M
机构
[1] Extracellular Matrix Pathol. Section, Laboratory of Pathology, National Institutes of Health, Bethesda
关键词
extracellular matrix; invasion; metastases; proteases; TIMPs;
D O I
10.1006/scbi.1996.0020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor cell invasion is now viewed as dysregulated physiologic invasion. Investigators have started to define the molecular events that are involved in this process. We find that there are many functional similarities with molecular events involved in physiologic process such as angiogenesis and wound healing. Matrix metalloproteinase activity is a common denominator in these pathologic conditions and in normal responses. Studies using endogenous metalloproteinase inhibitors suggest that targeting matrix metalloproteinase activity may prevent tumor cell dissemination. The development and pre-clinical testing of novel, low molecular weight matrix metalloproteinase inhibitors support this concept and suggest that an. exciting new era of cancer therapy is on the horizon.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 58 条
[1]   THE GENE STRUCTURE OF TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP)-3 AND ITS INHIBITORY ACTIVITIES DEFINE THE DISTINCT TIMP GENE FAMILY [J].
APTE, SS ;
OLSEN, BR ;
MURPHY, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14313-14318
[2]   ASSOCIATION OF MMP-2 ACTIVATION POTENTIAL WITH METASTATIC PROGRESSION IN HUMAN BREAST-CANCER CELL-LINES INDEPENDENT OF MMP-2 PRODUCTION [J].
AZZAM, HS ;
ARAND, G ;
LIPPMAN, ME ;
THOMPSON, EW .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (21) :1758-1764
[3]   A NOVEL METALLOPROTEINASE GENE SPECIFICALLY EXPRESSED IN STROMAL CELLS OF BREAST CARCINOMAS [J].
BASSET, P ;
BELLOCQ, JP ;
WOLF, C ;
STOLL, I ;
HUTIN, P ;
LIMACHER, JM ;
PODHAJCER, OL ;
CHENARD, MP ;
RIO, MC ;
CHAMBON, P .
NATURE, 1990, 348 (6303) :699-704
[4]   MATRIX METALLOPROTEINASES - A REVIEW [J].
BIRKEDALHANSEN, H ;
MOORE, WGI ;
BODDEN, MK ;
WINDSOR, LJ ;
BIRKEDALHANSEN, B ;
DECARLO, A ;
ENGLER, JA .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) :197-250
[5]  
BOAG AH, 1994, AM J PATHOL, V144, P585
[6]   ASSOCIATION BETWEEN EXPRESSION OF ACTIVATED 72-KILODALTON GELATINASE AND TUMOR SPREAD IN NON-SMALL-CELL LUNG-CARCINOMA [J].
BROWN, PD ;
BLOXIDGE, RE ;
STUART, NSA ;
GATTER, KC ;
CARMICHAEL, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (07) :574-578
[7]   EXPRESSION OF ACTIVATED GELATINASE IN HUMAN INVASIVE BREAST-CARCINOMA [J].
BROWN, PD ;
BLOXIDGE, RE ;
ANDERSON, E ;
HOWELL, A .
CLINICAL & EXPERIMENTAL METASTASIS, 1993, 11 (02) :183-189
[8]   CLINICAL-TRIALS OF A LOW-MOLECULAR-WEIGHT MATRIX METALLOPROTEINASE INHIBITOR IN CANCER [J].
BROWN, PD .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 :217-221
[9]  
DAVIES B, 1993, CANCER RES, V53, P2087
[10]   CHARACTERIZATION OF THE FUNCTIONAL DOMAIN OF TISSUE INHIBITOR OF METALLOPROTEINASES-2 (TIMP-2) [J].
DECLERCK, YA ;
YEAN, TD ;
LEE, Y ;
TOMICH, JM ;
LANGLEY, KE .
BIOCHEMICAL JOURNAL, 1993, 289 :65-69